REDEFINING MONOCLONAL ANTIBODY THERAPY

Serial Number 76604657
606

Registration Progress

Application Filed
Jul 21, 2004
Under Examination
Dec 27, 2005
Approved for Publication
Sep 14, 2005
Published for Opposition
Oct 4, 2005
Registered

Trademark Image

REDEFINING MONOCLONAL ANTIBODY THERAPY

Basic Information

Serial Number
76604657
Filing Date
July 21, 2004
Published for Opposition
October 4, 2005
Abandonment Date
June 28, 2006
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 28, 2006
Classes
044

Rights Holder

ImClone Systems Incorporated

03
Address
180 Varick Street, 6th Floor
New York, NY 10014

Ownership History

ImClone Systems Incorporated

Original Applicant
03
New York, NY

ImClone Systems Incorporated

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Robert M. Kunstadt

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

16 events
Date Code Type Description Documents
Aug 28, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 28, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 27, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 4, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 14, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Aug 8, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 5, 2005 ALIE A ASSIGNED TO LIE Loading...
Jul 29, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 26, 2005 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Jul 14, 2005 MAIL I PAPER RECEIVED Loading...
Jul 14, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 24, 2005 CPRA F PRIORITY ACTION MAILED Loading...
Feb 23, 2005 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 23, 2005 CPRA R PRIORITY ACTION WRITTEN Loading...
Feb 7, 2005 MAIL I PAPER RECEIVED Loading...
Aug 9, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
MEDICAL INFORMATION SERVICES RENDERED TO THE PUBLIC BY MEANS OF A GLOBAL COMPUTER INFORMATION NETWORK, PERTAINING TO CANCER, CANCER RESEARCH, TREATMENT OF CANCER, PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER, VACCINES AND DIAGNOSTIC PREPARATIONS
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MONOCLONAL ANTIBODY THERAPY"